Knee OsteoarthritisNCT02766231
Physica CR and Physica PS Clinical Trial
An observational study of Knee Osteoarthritis, run by Limacorporate S.p.a at 4 sites in 3 countries.
Trial summary
Type \& Design: Post-market, international, multicentre Prospective, parallel groups, open-label, baseline controlled Objectives: 1. Assessment of clinical, radiographic and patient-reported outcomes of Physica CR and PS designs 2. Read more about this study
- Who is it for?
- Ages 22 to 78 years
- Conditions the study is for
- Knee Osteoarthritis
- What is being tested?
- Physica CR and Physica PS
- Type of treatment
- Medical device
- How many people
- 157 participants
- Where
- 4 sitesin 3 countries
- Study dates
- Feb 2016to 30 Oct 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 to 78 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: General population of subjects requiring a primary TKR with a diagnosis of painful primary or secondary osteoartrithis not responding to other conservative treatments, after the review of medical history and the radiographic evaluation of the affected knee.
Who may be able to join
- Male and females
- Age 22-78 years
- Any race
- Ambulatory patients
- Patients who have a medical condition with over 5 years of life expectancy
- Patients with painful primary or secondary knee osteoarthritis
Show all 11Show fewer
- Patients who have undamaged and functional collateral and posterior cruciate ligaments for the group requiring Physica CR or Patients who have undamaged and functional collateral ligaments for the group requiring Physica PS
- Patients with flexion ≥90° on the affected side
- Patients with a fixed flexion contracture <20°
- Patients who understand the conditions of the study and are willing and able to comply with the prescribed rehabilitation and to perform all scheduled follow-up visits
- Patients who have signed the Ethics Committee approved study-specific Informed Consent Form prior to the surgery
Who cannot join
- Previous partial knee replacement or patellofemoral joint replacement and previous patellectomy
- Primary Total Knee Replacement (TKR) in the affected knee
- Varus deformity >20° or Valgus deformity >15°
- Patients with a fixed flexion contracture >20°
- Previous intra-articular fractures of the affected knee
- Patients with previous methaphysal tibial or femoral osteotomy performed less than 5 years before the screening visit, in case of plate removal surgery it is done early than 1 year ago to screening.
Show all 25Show fewer
- Previous knee replacement on the contralateral side within the last year and whose outcome is achieving an KSS< 60 points
- Patients with symptomatic Osteoarthritis (OA) of the spine if the assessment of pain with Numeric Rating Scale is >4
- Patients with an history of infections (on the affected knee or systemic)
- Muscular insufficiency or absence of muscoligamentous supporting structures required for adequate soft tissue balance
- Patients who have damaged or absence of the posterior cruciate ligament for the group requiring Physica CR
- Patients with known or suspicious metal hypersensitivity
- Recurrent medical history of severe allergic or immune-mediated reactions
- Vascular insufficiency of lower limbs severe enough to interfere with the study evaluation
- Current treatment or treatment within the previous 2 years before the screening visit for malignant and life-threatening non-malignant disorders
- Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation including:
- any intercurrent chronic disease or condition that may interfere with the completion of the 5-year follow-up, such as liver disease, severe coronary disease, drug or alcohol abuse
- significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery
- neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device
- known metabolic disorders leading to progressive bone deterioration
- Patients who have known co-existent medical condition with less 5 years of life expectancy
- Previous organ transplant surgery
- Any psychiatric illness that would prevent comprehension of the details and nature of the study
- Participation in any experimental drug/device study within the 6 months prior to the screening visit
- Female patients who are pregnant, nursing, or planning a pregnancy
Trial locations and contacts
4 sites in 3 countries.
4 sites in 3 countries
Italy2 sites
I.R.C.C.S. Galeazzi
Milan, Milano, 20161
Casa di cura Citta' di Parma
Parma, Parma, 43100
Belgium1 site
Cliniques Universitaires Saint-Luc ASBL
Brussels, Brussels Capital, 1200
Luxembourg1 site
Clinique d'Eich - centre Hospitalier de Luxembourg
Luxembourg, Luxembourg, 1460
About this study
Official title: A Multicentre, Prospective Study Evaluating Clinical, Radiographic and Patient-reported Outcomes of Total Knee Arthroplasty With Physica CR or Physica PS Prosthesis
Type \& Design:
Post-market, international, multicentre Prospective, parallel groups, open-label, baseline controlled
Objectives:
- Assessment of clinical, radiographic and patient-reported outcomes of Physica CR and PS designs
- Incidence of adverse events and identification of possible risk factors for unsatisfactory results
- Mid-term survivorship of the implants
- Conditions
- Knee Osteoarthritis
- Being tested
- Physica CR, Physica PS
- Keywords
- knee replacement
- Medical subject headings
- Osteoarthritis, Knee
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physica CRDevice
Cruciate retaining total knee replacement
Physica PSDevice
Posterior Stabilized total knee replacement
| Study group | Role | What they receive |
|---|---|---|
| Physica CR | Patients who have undamaged and functional collateral and posterior cruciate ligaments for the group requiring Physica CR Receives: Device: Physica CR | |
| Physica PS | Patients who have undamaged and functional collateral ligaments for the group requiring Physica PS Receives: Device: Physica PS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical change in Knee Society Score (KSS)
KSS is divided into two components: the first ("Knee Score", KKSS) assesses the knee clinically through the physical examination, and the second ("Function Score", FKSS) assesses the individual's functionality, while both attain a total of 100 points each. The Clinical KSS (KKSS) evaluates pain (50 points), stability (25 points) and range of motion (25 points). The Functional KSS (FKSS) evaluates the walking distance (50 points), and the act of climbing and descending stairs (50 points).
The system for selecting patients is provided through three categories: A- unilateral or bilateral (opposite knee replaced successfully), B- unilateral, other knee symptomatic and C- polyarthritis or clinical disease.
Scores rating from 80 to 100 is considered excellent, from 70 to 79 good, from 60 to 69 fair, and less than 60 poor.
Measured: From preoperative (baseline) to 5 years after surgery
Secondary outcomes (7)
Functional change in Timed up and Go (TUG) test
The Timed-get-up-and-go test (TUG) is a simple test widely used to assess a person's mobility, requiring both static and dynamic balance. Subjects are instructed to walk as quickly as they feel safe and comfortable. Time (seconds) is taken to rise from a chair (seat height, 46 cm), walk 3 meters, turn around, walk back to the chair, then sit down wearing regular footwear. The TUG has excellent inter-rater and intra-rater reliability. Timing starts on the signal to start and terminates once the participant sits back down fully with their back resting on the back of the chair. Regular walking aid is allowed and recorded if required. Two trials are performed and the faster of the 2 trials is recorded to nearest 10th of a second.
Measured: From preoperative (baseline) to 5 years after surgery
Change in Knee injury and Osteoarthritis Outcome Score (KOOS)
KOOS was developed and is validated for several cohorts of younger and/or more active patients with knee injury and/or knee osteoarthritis. KOOS is a 42-item self-administered self-explanatory questionnaire that covers five patient-relevant dimensions: Pain, Other Disease-Specific Symptoms, Active Daily Living Function, Sport and Recreation Function, and knee-related Quality of Life. The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures.
Measured: From preoperative (baseline) to 5 years after surgery
Change in Satisfaction Visual Analogue Scale (Satisfaction VAS)
A Satisfaction Visual Analogue Scale (VAS) system was developed to evaluate patient satisfaction with the TKR at follow-up, similar to the system used to measure pain. The scale consists of a 10-cm-long horizontal line ranging from completely satisfied to totally unsatisfied. On top of the scale the question: "Are you satisfied with your knee prosthesis?" is placed. Facial expressions are put above the line to express satisfaction visually. The patient receives this scale and is asked to mark the line at a point that would match his/her satisfaction. With a ruler, the number of millimetres is measured and converted to points. The satisfaction VAS system ranges from 100 (best, completely satisfied) to 0 (worst, totally unsatisfied) points.
Measured: From 3 months to 5 years after surgery
Change in Forgotten Joint Score (FJS-12)
The Forgotten Joint Scores (FJS-12) comprises measures for the assessment of joint-specific patient-reported outcome and focus on patients' awareness of a specific joint in everyday life. FJS-12 is a 12-item questionnaire that integrates variables such as pain, stiffness, function on activities of daily living, patients' expectations and activity levels and finally psychosocial factors. It consists of 12 questions and is scored using a 5-point Likert response format (never-almost never-seldom-sometimes-mostly) with the raw scores transformed onto a 0-100 point scale. High scores indicate good outcome, that is, a high degree of "forgetting" the joint. FJS-12 evaluation isn't performed preoperatively.
Measured: From 3 months to 5 years after surgery
Components stability - radiolucent lines evaluation
The radiographical assessment includes a modified evaluation of presence, location and thickness of periprosthetic radiolucent lines. The sums of the width of radiolucent lines for every component are categorised as follows: 4 or less and non progressive is probably not significant; 5-9 should be closely followed for progression; 10 or greater signifies possible or impending failure regardless of symptoms. Signs of a radiographically loose prosthesis include progressively enlarging luciencies, subsidence of the component or a change in alignment from previous films.
Measured: From discharge to 5 years after surgery
Survival rate of Physica CR and PS
Survival rate of the implant (Kaplan-Meier)
Measured: At 3 years and 5 years after surgery
Incidence of device-related AE/SAE/DD/ADE/SADE
Incidence of device-related adverse events( AE), serious adverse events (SAE), device deficiency (DD), adverse device effect (ADE), serious adverse device effect (SADE).
Measured: From intraoperative to 5 years after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 May 2016 (estimated)
- Study startFeb 2016
- Primary completion30 Oct 2027 (estimated)
- Study completion30 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Knee OsteoarthritisStudies of the same condition, open and under way.
- More trials run by Limacorporate S.p.aThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 157 participants (actual)
Sponsor and investigators
- Lead sponsor
- Limacorporate S.p.a
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Giuseppe Peretti, MD, Principal investigator, I.R.C.C.S. Galeazzi (Milan, Italy)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02766231
- Sponsor's protocol ID
- K-09
- Status last verified
- Aug 2026
- First submitted
- 4 May 2016
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multicentre, Prospective Study Evaluating Clinical, Radiographic and Patient-reported Outcomes of Total Knee Arthroplasty With Physica CR or Physica PS Prosthesis
- ClinicalTrials.gov ID
- NCT02766231
- Acronym / sponsor ID
- K-09
- Conditions
- Knee Osteoarthritis
- Keywords
- knee replacement
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 157 participants (actual)
- Lead sponsor
- Limacorporate S.p.aIndustry (pharma, biotech, devices)
- Study start
- Feb 2016 (actual)
- Primary completion
- 30 Oct 2027 (estimated)
- Study completion
- 30 Oct 2027 (estimated)
- First posted
- 9 May 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Type \& Design:
Post-market, international, multicentre Prospective, parallel groups, open-label, baseline controlled
Objectives:
- Assessment of clinical, radiographic and patient-reported outcomes of Physica CR and PS designs
- Incidence of adverse events and identification of possible risk factors for unsatisfactory results
- Mid-term survivorship of the implants
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Physica CR | – | Device: Physica CRPatients who have undamaged and functional collateral and posterior cruciate ligaments for the group requiring Physica CR |
| Physica PS | – | Device: Physica PSPatients who have undamaged and functional collateral ligaments for the group requiring Physica PS |
Who may qualify
- Ages
- 22 to 78 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- General population of subjects requiring a primary TKR with a diagnosis of painful primary or secondary osteoartrithis not responding to other conservative treatments, after the review of medical history and the radiographic evaluation of the affected knee.
Key inclusion criteria (11 listed)
- Male and females
- Age 22-78 years
- Any race
- Ambulatory patients
- Patients who have a medical condition with over 5 years of life expectancy
Key exclusion criteria (25 listed)
- Previous partial knee replacement or patellofemoral joint replacement and previous patellectomy
- Primary Total Knee Replacement (TKR) in the affected knee
- Varus deformity >20° or Valgus deformity >15°
- Patients with a fixed flexion contracture >20°
- Previous intra-articular fractures of the affected knee
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physica CRCruciate retaining total knee replacement | Device | Physica CR |
| Physica PSPosterior Stabilized total knee replacement | Device | Physica PS |
Primary outcome
Clinical change in Knee Society Score (KSS)
Time frame: From preoperative (baseline) to 5 years after surgery
KSS is divided into two components: the first ("Knee Score", KKSS) assesses the knee clinically through the physical examination, and the second ("Function Score", FKSS) assesses the individual's functionality, while both attain a total of 100 points each. The Clinical KSS (KKSS) evaluates pain (50 points), stability (25 points) and range of motion (25 points). The Functional KSS (FKSS) evaluates the walking distance (50 points), and the act of climbing and descending stairs (50 points). The system for selecting patients is provided through three categories: A- unilateral or bilateral (opposite knee replaced successfully), B- unilateral, other knee symptomatic and C- polyarthritis or clinical disease. Scores rating from 80 to 100 is considered excellent, from 70 to 79 good, from 60 to 69 fair, and less than 60 poor.
7 secondary outcomes
Functional change in Timed up and Go (TUG) test
Time frame: From preoperative (baseline) to 5 years after surgery
Change in Knee injury and Osteoarthritis Outcome Score (KOOS)
Time frame: From preoperative (baseline) to 5 years after surgery
Change in Satisfaction Visual Analogue Scale (Satisfaction VAS)
Time frame: From 3 months to 5 years after surgery
Change in Forgotten Joint Score (FJS-12)
Time frame: From 3 months to 5 years after surgery
Components stability - radiolucent lines evaluation
Time frame: From discharge to 5 years after surgery
Survival rate of Physica CR and PS
Time frame: At 3 years and 5 years after surgery
Incidence of device-related AE/SAE/DD/ADE/SADE
Time frame: From intraoperative to 5 years after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Knee Osteoarthritis
RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Recruiting
ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty
Knee Osteoarthritis
RecruitingPhase 3
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Obesity, Overweight
Recruiting
SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty
Knee Osteoarthritis
Recruiting
BioPoly® Partial Resurfacing Knee Implant IDE
Knee Pain Chronic, Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Giuseppe Peretti, MD principal investigator
I.R.C.C.S. Galeazzi (Milan, Italy)
4 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Knee Osteoarthritis, run by Limacorporate S.p.a at 4 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Italy, Belgium, Luxembourg. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical change in Knee Society Score (KSS) (time frame: From preoperative (baseline) to 5 years after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.